Top

Journal of Cancer Survivorship

Published in:

01-12-2018

Patient and provider communication about employment following a cancer diagnosis

Authors: Janet S. de Moor, Kisha Coa, Erin E. Kent, Carmen Moten, Sarah Kobrin, Cheryl Altice, K. Robin Yabroff

Published in: Journal of Cancer Survivorship | Issue 6/2018

Abstract

Purpose

Cancer treatment can precipitate functional limitations that restrict survivors’ ability to work. Yet, it is unclear whether healthcare providers discuss the potential for employment limitations with their patients. We assessed the frequency of patient-provider communication about employment, from the perspectives of survivors, and examined whether receiving a treatment summary was associated with employment communication.

Methods

Cancer survivors who were working at diagnosis were identified from the Health Information National Trends Survey-4, conducted in 2014 (n = 290). Separate multivariable regression analyses examined the associations between survivor characteristics and employment communication and receipt of a treatment summary and employment communication.

Results

Among cancer survivors who were working at diagnosis, 62.69% (95% CI 54.42–70.95) reported discussing employment with any healthcare provider at any time since diagnosis. Younger cancer survivors and those more recently treated were more likely to ever have employment discussions. Survivors who received a treatment summary were also more likely to ever discuss employment with any healthcare provider than survivors who did not receive a treatment summary (OR = 3.47, 95% CI 1.02–11.84).

Conclusions

Approximately two thirds of cancer survivors who were working at diagnosis ever discussed employment with a healthcare provider. Thus, for a sizable portion of cancer survivors, the potential impact of cancer on employment is never discussed with any healthcare provider.

Implications for Cancer Survivors

Efforts are needed to proactively screen patients for cancer-related work limitations, empower patients to discuss employment concerns with their healthcare providers, and develop interventions that support survivors’ goals for working throughout treatment and recovery.

Feuerstein M, Todd BL, Moskowitz MC, Bruns GL, Stoler MR, Nassif T, et al. Work in cancer survivors: a model for practice and research. J Cancer Surviv. 2010;4(4):415–37. https://doi.org/10.1007/s11764-010-0154-6.CrossRefPubMed

de Boer AG, Taskila T, Ojajarvi A, van Dijk FJ, Verbeek JH. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62. https://doi.org/10.1001/jama.2009.187.CrossRefPubMed

Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30. https://doi.org/10.1016/j.critrevonc.2010.01.004.CrossRefPubMed

Lindbohm ML, Kuosma E, Taskila T, Hietanen P, Carlsen K, Gudbergsson S, et al. Early retirement and non-employment after breast cancer. Psycho-Oncology. 2014;23(6):634–41. https://doi.org/10.1002/pon.3459.CrossRefPubMed

Steiner JF, Cavender TA, Nowels CT, Beaty BL, Bradley CJ, Fairclough DL, et al. The impact of physical and psychosocial factors on work characteristics after cancer. Psycho-Oncology. 2008;17(2):138–47. https://doi.org/10.1002/pon.1204.CrossRefPubMed

Steiner JF, Cavender TA, Main DS, Bradley CJ. Assessing the impact of cancer on work outcomes. Cancer. 2004;101(8):1703–11.CrossRefPubMed

de Boer AG, Verbeek JH, Spelten ER, Uitterhoeve AL, Ansink AC, de Reijke TM, et al. Work ability and return-to-work in cancer patients. Br J Cancer. 2008;98(8):1342–7. https://doi.org/10.1038/sj.bjc.6604302.CrossRefPubMedPubMedCentral

Islam T, Dahlui M, Majid HA, Nahar AM, Mohd Taib NA, Su TT, et al. Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health. 2014;14(Suppl 3):S8. https://doi.org/10.1186/1471-2458-14-S3-S8.CrossRefPubMedPubMedCentral

Horsboel TA, Bultmann U, Nielsen CV, Nielsen B, Andersen NT, de Thurah A. Are fatigue, depression and anxiety associated with labour market participation among patients diagnosed with haematological malignancies? A prospective study. Psycho-Oncology. 2015;24(4):408–15. https://doi.org/10.1002/pon.3658.CrossRefPubMed

10.

Moskowitz MC, Todd BL, Chen R, Feuerstein M. Function and friction at work: a multidimensional analysis of work outcomes in cancer survivors. J Cancer Surviv. 2014;8(2):173–82. https://doi.org/10.1007/s11764-013-0340-4.CrossRefPubMed

11.

Fossa SD, Vassilopoulou-Sellin R, Dahl AA. Long term physical sequelae after adult-onset cancer. J Cancer Surviv. 2008;2(1):3–11. https://doi.org/10.1007/s11764-007-0039-5.CrossRefPubMed

12.

Reeve BB, Potosky AL, Smith AW, Han PK, Hays RD, Davis WW, et al. Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst. 2009;101(12):860–8. https://doi.org/10.1093/jnci/djp123.CrossRefPubMedPubMedCentral

13.

Alfano CM, Rowland JH. Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J. 2006;12(5):432–43.CrossRefPubMed

14.

Polsky D, Doshi JA, Marcus S, Oslin D, Rothbard A, Thomas N, et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med. 2005;165(11):1260–6. https://doi.org/10.1001/archinte.165.11.1260.CrossRefPubMed

15.

Berger AM, Visovsky C, Hertzog M, Holtz S, Loberiza FR Jr. Usual and worst symptom severity and interference with function in breast cancer survivors. J Support Oncol. 2012;10(3):112–8. https://doi.org/10.1016/j.suponc.2011.11.001.CrossRefPubMed

16.

Berger AM, Gerber LH, Mayer DK. Cancer-related fatigue: implications for breast cancer survivors. Cancer. 2012;118(8 Suppl):2261–9. https://doi.org/10.1002/cncr.27475.CrossRefPubMed

17.

Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103(6):1292–301. https://doi.org/10.1002/cncr.20912.CrossRefPubMed

18.

Horsboel TA, De Thurah A, Nielsen B, Nielsen CV. Factors associated with work outcome for survivors from haematological malignancies—a systematic literature review. Eur J Cancer Care. 2012;21(4):424–35. https://doi.org/10.1111/j.1365-2354.2012.01348.x.CrossRef

19.

Blinder V, Eberle C, Patil S, Gany FM, Bradley CJ. Women with breast cancer who work for accommodating employers more likely to retain jobs after treatment. Health Aff (Project Hope). 2017;36(2):274–81. https://doi.org/10.1377/hlthaff.2016.1196.CrossRef

20.

Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse SF et al., editors. SEER cancer statistics review, 1975–2011. Bethesda, MD: National Cancer Institute; based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

21.

Older Workers. BLS spotlight on statistics, Washington, D.C.; 2008.

22.

Stergiou-Kita M, Grigorovich A, Tseung V, Milosevic E, Hebert D, Phan S, et al. Qualitative meta-synthesis of survivors' work experiences and the development of strategies to facilitate return to work. J Cancer Surviv. 2014;8(4):657–70. https://doi.org/10.1007/s11764-014-0377-z.CrossRefPubMed

23.

Steiner JF, Nowels CT, Main DS. Returning to work after cancer: quantitative studies and prototypical narratives. Psycho-Oncology. 2010;19(2):115–24. https://doi.org/10.1002/pon.1591.CrossRefPubMedPubMedCentral

24.

Zajacova A, Dowd JB, Schoeni RF, Wallace RB. Employment and income losses among cancer survivors: estimates from a national longitudinal survey of American families. Cancer. 2015;121(24):4425–32. https://doi.org/10.1002/cncr.29510.CrossRefPubMed

25.

Syse A, Tretli S, Kravdal O. Cancer's impact on employment and earnings—a population-based study from Norway. J Cancer Surviv. 2008;2(3):149–58. https://doi.org/10.1007/s11764-008-0053-2.CrossRefPubMed

26.

Hewitt M, Greenfield S, Stoval E, editors. From cancer patient to cancer survivor: lost in transition. Washington, D.C.: The National Academies Press; 2006.

27.

Pryce J, Munir F, Haslam C. Cancer survivorship and work: symptoms, supervisor response, co-worker disclosure and work adjustment. J Occup Rehabil. 2007;17(1):83–92. https://doi.org/10.1007/s10926-006-9040-5.CrossRefPubMed

28.

Paltrinieri S, Fugazzaro S, Bertozzi L, Bassi MC, Pellegrini M, Vicentini M, et al. Return to work in European cancer survivors: a systematic review. Support Care Cancer. 2018;26(9):2983–94. https://doi.org/10.1007/s00520-018-4270-6.CrossRefPubMed

29.

Luker K, Campbell M, Amir Z, Davies L. A UK survey of the impact of cancer on employment. Occup Med (Oxford, England). 2013;63(7):494–500. https://doi.org/10.1093/occmed/kqt104.CrossRef

30.

Jiang Y, Elemento O. Tracing the roots of cancer evolution. Cancer Discov. 2014;4(9):995–7. https://doi.org/10.1158/2159-8290.cd-14-0743.CrossRefPubMedPubMedCentral

31.

Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev. 2016;25(7):1029–36. https://doi.org/10.1158/1055-9965.epi-16-0133.CrossRef

32.

2014 National Population Projections Tables [database on the Internet]. United States Census Bureau. 2014. Accessed 20 Aug 2018.

33.

Yabroff KR, Short PF, Machlin S, Dowling E, Rozjabek H, Li C, et al. Access to preventive health care for cancer survivors. Am J Prev Med. 2013;45(3):304–12. https://doi.org/10.1016/j.amepre.2013.04.021.CrossRefPubMedCentral

34.

Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010;116(14):3493–504. https://doi.org/10.1002/cncr.25209.CrossRefPubMed

35.

Graubard BI, Korn EL. Predictive margins with survey data. Biometrics. 1999;55(2):652–9.CrossRefPubMed

36.

Explore Sudaan 11: Statistical software for weighting, imputing, and analyzing data: RTI International; 2016 [cited 2016 8/8/2016]. Available from: https://www.rti.org/impact/sudaan-statistical-software-analyzing-correlated-data.

37.

Kennedy F, Haslam C, Munir F, Pryce J. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care. 2007;16(1):17–25. https://doi.org/10.1111/j.1365-2354.2007.00729.x.CrossRef

38.

Tamminga SJ, de Boer AG, Verbeek JH, Frings-Dresen MH. Breast cancer survivors' views of factors that influence the return-to-work process—a qualitative study. Scand J Work Environ Health. 2012;38(2):144–54. https://doi.org/10.5271/sjweh.3199.CrossRefPubMed

39.

Main DS, Nowels CT, Cavender TA, Etschmaier M, Steiner JF. A qualitative study of work and work return in cancer survivors. Psycho-Oncology. 2005;14(11):992–1004. https://doi.org/10.1002/pon.913.CrossRefPubMed

40.

Bains M, Yarker J, Amir Z, Wynn P, Munir F. Helping cancer survivors return to work: what providers tell us about the challenges in assisting cancer patients with work questions. J Occup Rehabil. 2012;22(1):71–7. https://doi.org/10.1007/s10926-011-9330-4.CrossRefPubMed

41.

Boyajian RN, Grose A, Grenon N, Roper K, Sommer K, Walsh M, et al. Desired elements and timing of cancer survivorship care: one approach may not fit all. J Oncol Pract. 2014;10(5):e293–8. https://doi.org/10.1200/jop.2013.001192.CrossRefPubMedPubMedCentral

42.

Murphy KM, Nguyen V, Shin K, Sebastian-Deutsch A, Frieden L. Health care professionals and the employment-related needs of cancer survivors. J Occup Rehabil. 2017;27(2):296–305. https://doi.org/10.1007/s10926-016-9629-2.CrossRefPubMed

43.

Meunier J, Fautrel B, Roquelaure Y, Claudepierre P. Work-related discussions between French rheumatologists and their rheumatoid arthritis patients. Occup Med (Oxford, England). 2016;66(6):454–9. https://doi.org/10.1093/occmed/kqw031.CrossRef

44.

Coole C, Watson PJ, Drummond A. Work problems due to low back pain: what do GPs do? A questionnaire survey. Fam Pract. 2010;27(1):31–7. https://doi.org/10.1093/fampra/cmp074.CrossRefPubMed

45.

Denne J, Kettner G, Ben-Shalom Y. The role of the physician in the return-to-work process following disability onset. Washington, DC: Mathematica Center for Studying Disability Policy 2015; 2015.

46.

Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Investig. 2007;25(1):47–54. https://doi.org/10.1080/07357900601130664.CrossRef

47.

Dorland HF, Abma FI, SKR VZ, Stewart RE, Amick BC, Ranchor AV, et al. Fatigue and depressive symptoms improve but remain negatively related to work functioning over 18 months after return to work in cancer patients. J Cancer Surviv. 2018;12(3):371–8. https://doi.org/10.1007/s11764-018-0676-x.CrossRefPubMedPubMedCentral

48.

Alfano CM, Kent EE, Padgett LS, Grimes M, de Moor JS. Making cancer rehabilitation services work for cancer patients: recommendations for research and practice to improve employment outcomes. PM R. 2017;9s2(9):S398–s406. https://doi.org/10.1016/j.pmrj.2017.06.019.CrossRef

49.

Blanch-Hartigan D, Chawla N, Beckjord EI, Forsythe LP, de Moor JS, Hesse BW, et al. Cancer survivors’ receipt of treatment summaries and implications for patient-centered communication and quality of care. Patient Educ Couns. 2015;98(10):1274–9. https://doi.org/10.1016/j.pec.2015.06.005.CrossRefPubMedPubMedCentral

50.

Sabatino SA, Thompson TD, Smith JL, Rowland JH, Forsythe LP, Pollack L, et al. Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. J Cancer Surviv. 2013;7(1):32–43. https://doi.org/10.1007/s11764-012-0242-x.CrossRefPubMed

Title: Patient and provider communication about employment following a cancer diagnosis
Authors: Janet S. de Moor
Kisha Coa
Erin E. Kent
Carmen Moten
Sarah Kobrin
Cheryl Altice
K. Robin Yabroff
Publication date: 01-12-2018
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 6/2018
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-018-0718-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 6/2018

The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study

Smoking cessation among men following cancer diagnosis: a matched cohort study

Survivorship care planning in gynecologic oncology—perspectives from patients, caregivers, and health care providers

Cognitive challenges while at work and work output in breast cancer survivors employed in a rapidly evolving economy

Quality of diabetes care in breast, colorectal, and prostate cancer

Assessing the relationship between fear of cancer recurrence and health care utilization in early-stage breast cancer survivors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer